Low molecular weight heparin as an anticoagulation strategy for left-sided ablation procedures

Karen Hinsley, Margaret Evans-Langhorst, Courtney Porter, Stephanie Frances Chandler, Christina VanderPluym, John Triedman, Vassilios J. Bezzerides*

*Corresponding author for this work

Research output: Contribution to journalArticle

Abstract

Objective: This quality improvement study was implemented to demonstrate consistent and reliable post procedure anticoagulation for patients undergoing left-sided ablations. We evaluated the safety and efficacy of anticoagulation practice during a transition from anticoagulation with overnight infusion of unfractionated heparin to a single subcutaneous injection of low molecular weight heparin. Methods: Outcomes for patients who received unfractionated heparin from January 2014 to October 2014, were compared with outcomes of patients who received low molecular weight heparin from October 2014 to October 2015. Complications prepractice and postpractice change were documented and compared to establish confidence in the practice change and confirm the safety of the anticoagulation therapy management. Results: There were no differences in the type or frequency of complications/adverse events demonstrated between the patients who had received unfractionated heparin for anticoagulation prophylaxis and those who received low molecular weight heparin. No thromboembolic events were reported or documented with either anticoagulation strategy. After confidence in the safety and efficacy of the practice change was established, a decision was made to discharge patients home the same day as there procedure, effectively reducing inpatient bed days and overall costs. Conclusion: Administration of low molecular weight heparin provides predictable anticoagulation and equally safe as unfractionated heparin when administered to patients post left-sided ablation. A secondary gain has been reduction of procedural costs by elimination of the previously required inpatient observation stay.

Original languageEnglish (US)
Pages (from-to)222-225
Number of pages4
JournalCongenital Heart Disease
Volume13
Issue number2
DOIs
StatePublished - Mar 1 2018

Keywords

  • ablation
  • anticoagulation
  • electrophysiology
  • low molecular weight heparin

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Surgery
  • Radiology Nuclear Medicine and imaging
  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Low molecular weight heparin as an anticoagulation strategy for left-sided ablation procedures'. Together they form a unique fingerprint.

  • Cite this

    Hinsley, K., Evans-Langhorst, M., Porter, C., Chandler, S. F., VanderPluym, C., Triedman, J., & Bezzerides, V. J. (2018). Low molecular weight heparin as an anticoagulation strategy for left-sided ablation procedures. Congenital Heart Disease, 13(2), 222-225. https://doi.org/10.1111/chd.12551